ENDONOVO THERAPEUTICS, INC. (ENDV) Shareholders’ equity 2011–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) shareholders’ equity at each fiscal year-end, per SEC filings.
-$32.2MFY2022 · since FY2011: -$447,227 → -$32.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$32.2M | -104.0% |
| FY2021 | -$15.8M | -9.7% |
| FY2020 | -$14.4M | +29.9% |
| FY2019 | -$20.5M | -80.0% |
| FY2018 | -$11.4M | — |
| FY2015 | -$9.3M | -97.7% |
| FY2014 | -$4.7M | -13.6% |
| FY2013 | -$4.1M | -119.7% |
| FY2012 | -$1.9M | -320.6% |
| FY2011 | -$447,227 | — |
Source: SEC XBRL filings · For reference only · Not investment advice